-
Why Shares of Immunomedics Inc Are up an Astounding 89% in 2017
Post on 3/29/17
-
Milner Therapeutics Institute Announces New Partnership with Elysium Health
Post on 3/28/17
-
Empire BlueCross BlueShield and IPANS Renew and Expand Collaborative Agreement to Improve Health Outcomes
Post on 3/28/17
-
Arno Therapeutics Announces Plan to Deregister its Common Stock
Post on 3/28/17
-
Teva: Outstanding Buying Opportunity Ahead
Post on 3/28/17
-
Invivotek Completes Solar Farm and Facility Expansion
Post on 3/27/17
-
Neurotrope Announces Approval for Listing on the NASDAQ Capital Market
Post on 3/27/17
-
Advanced Radiology Consultants Recognized for Physician Marketing
Post on 3/27/17
-
Peconic Bay Medical Center Celebrates State Approval For New Cardiac Care Center
Post on 3/27/17
-
Johnson & Johnson's CEO Believes Trump Is Missing the Point on Drug-Price Reform
Post on 3/27/17
-
Pfizer and the National Newspaper Publishers Association Collaborate
Post on 3/26/17
-
Interpace Diagnostics Group Announces Agreements to Successfully Restructure Debt and Terminate Royalty and Milestone Obligations
Post on 3/23/17
-
SkinCeuticals Announces Advanced Clinical Spa At Betty Rajan, M.D.
Post on 3/23/17
-
Symbiomix Therapeutics Announces FDA’s Acceptance of New Drug Application for Solosec with Priority Review Status
Post on 3/23/17
-
Johnson & Johnson: Great Business With A Great Future - A Great Time To Buy?
Post on 3/23/17
-
Pfizer Is Positioned For Dividend Growth With Limited Downside
Post on 3/23/17
-
Tyme Technologies Announces $8.2 Million Private Placement
Post on 3/22/17
-
Q BioMed Completes 2nd Closing on $4,000,000 Funding
Post on 3/22/17
-
Billionaires' Best Healthcare Stock Picks of 2017 (So Far)
Post on 3/22/17
-
ProCure Proton Therapy New Jersey Celebrates Five Years of Service to Cancer Community
Post on 3/21/17
-
22nd Century Group Issues Annual Letter to Shareholders
Post on 3/21/17
-
Axsome Therapeutics Prices Public Offering of Common Stock
Post on 3/21/17
-
Dividend Expectations From Johnson & Johnson
Post on 3/21/17
-
Johnson & Johnson Has Let Shareholders Down
Post on 3/21/17
-
Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration
Post on 3/20/17
New York
